Predictmedix AI Unveils Advanced AI Health Stations for US Market Expansion
Predictmedix AI Expands into US Market with Launch of Advanced AI Health Stations
Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a pioneering provider of AI-powered health screening solutions, has officially launched its enhanced Smart Health AI Stations across the United States. This strategic expansion positions Predictmedix to capitalize on the rapidly growing population health management market and revolutionize the way health screenings are conducted in workplaces, healthcare facilities, public venues, and government institutions.
A Transformational Step for Predictmedix AI
“The US launch of our Smart Health AI Stations marks an important step in our mission to advance proactive health management,” stated Dr. Rahul Kushwah, COO of Predictmedix AI. “Through our partnership with Manchester Marketing Group Inc., we look forward to identifying opportunities to provide organizations with the tools they need to prioritize health, safety, and well-being. Our comprehensive data and experience position us to offer valuable health management solutions in the US market.”
As part of this strategic launch, Predictmedix AI has partnered with Manchester Marketing Group Inc. to introduce state-of-the-art AI-powered health assessments. These Smart Health AI Stations utilize real-time vitals screening and substance-induced impairment detection to enhance safety and improve overall health management. Currently, ten units are under consideration for potential showcasing to corporate and government entities across the United States.
Manchester Marketing Group Inc., a US-based firm, is working with partners across North America, Central America, South America, and the Caribbean to expand the reach of Predictmedix AI’s innovative health screening technology.
How the Smart Health AI Station Works
The Smart Health AI Station is designed to provide instant, non-contact health screenings using artificial intelligence. By analyzing real-time health data, the AI-powered system can detect potential health risks, enabling organizations to transition from reactive to preventive care strategies. Predictmedix AI’s extensive health-related dataset enhances the accuracy and reliability of these screenings, making them a powerful tool for organizations looking to improve health management and safety protocols.
Key capabilities of the Smart Health AI Station include:
- Real-time vitals detection: Monitors key health indicators such as heart rate, blood pressure, and temperature.
- Impairment detection: Uses AI to identify signs of substance-induced impairment, helping to enhance workplace and public safety.
- Non-contact assessments: Reduces the risk of disease transmission by eliminating the need for physical contact during screenings.
- Data-driven insights: Provides organizations with actionable health data to improve workplace wellness and risk management.
Market Opportunity & Growth Potential
The population health management market is expanding rapidly, presenting a significant opportunity for Predictmedix AI. According to industry reports, the market was valued at USD 32.94 billion in 2023 and is projected to grow to USD 126.16 billion by 2032, with a compound annual growth rate (CAGR) of 16.6%. North America currently dominates the market with a 64.81% share, making the US a prime target for Predictmedix AI’s expansion.
By leveraging AI-driven solutions, Predictmedix AI aims to tap into this booming market and establish itself as a key player in the health technology sector. The company’s AI-powered Smart Health Stations are expected to drive adoption across multiple industries, enabling organizations to implement proactive health management strategies efficiently.
Strategic Business Relationships & Global Reach
Beyond the US market, Predictmedix AI is strengthening its presence in international markets through strategic partnerships. Manchester Marketing Group Inc. has also announced a business relationship with Dr. Aftab Ahmed and his network of 4,000 physicians throughout Pakistan and Dubai. Additionally, Dr. Harriette Kamendi’s program in Sub-Saharan Africa is collaborating with Predictmedix AI to bring AI-powered health screening technology to emerging markets.
These partnerships align with Predictmedix AI’s broader mission to transform health management on a global scale. By showcasing the capabilities of Smart Health AI Stations in various regions, the company aims to accelerate adoption and expand its market footprint.
Applications Across Multiple Sectors
The Smart Health AI Stations have the potential to revolutionize health screenings across various industries. Their key applications include:
- Workplace Wellness – Organizations can implement proactive health screenings and data-driven wellness programs to ensure employee safety and productivity.
- Healthcare Screening – Hospitals and clinics can enhance patient and visitor screening for infection control and overall safety.
- Public Safety – Large venues and events can utilize AI-powered health stations to monitor and manage crowd health effectively.
- Education Sector – Schools and universities can improve student and staff wellness by integrating real-time health assessments.
- Government Institutions – Public buildings can benefit from ongoing health management measures to protect employees and visitors.
Benefits of Predictmedix AI’s Smart Health AI Stations
- Real-time Health Screening: Enables quick and accurate assessments without the need for invasive procedures.
- Non-Contact Technology: Reduces the risk of disease transmission, particularly in high-traffic environments.
- AI-Powered Impairment Detection: Helps organizations maintain safety standards by identifying potential risks associated with substance use.
- Data-Driven Decision Making: Provides valuable insights that organizations can use to develop targeted health and wellness strategies.
- Scalability: Can be deployed across various locations and industries to meet the evolving needs of different organizations.
Corporate Update: Option Grant Amendment
In addition to the product launch, Predictmedix AI has announced an amendment to a previously issued option grant to a consultant. Initially announced on February 21, 2025, the options were originally stated to have a one-year term. However, the term has now been revised to five years. All other terms, including the number of options granted and the exercise price, remain unchanged.
This amendment reflects Predictmedix AI’s commitment to long-term strategic growth and investment in human capital, ensuring the company continues to attract and retain top talent.
